Analysts Set Privia Health Group, Inc. (NASDAQ:PRVA) Price Target at $28.00

Privia Health Group, Inc. (NASDAQ:PRVA) has earned a consensus rating of “Moderate Buy” from the thirteen analysts that are currently covering the company, MarketBeat.com reports. Two research analysts have rated the stock with a hold recommendation, ten have issued a buy recommendation and one has assigned a strong buy recommendation to the company. The average twelve-month price objective among analysts that have issued ratings on the stock in the last year is $28.00.

PRVA has been the topic of several recent analyst reports. Piper Sandler dropped their price objective on Privia Health Group from $36.00 to $35.00 and set an “overweight” rating on the stock in a research report on Monday, August 11th. Zacks Research raised shares of Privia Health Group from a “strong sell” rating to a “hold” rating in a report on Tuesday, August 19th. JPMorgan Chase & Co. increased their price objective on shares of Privia Health Group from $29.00 to $32.00 and gave the company an “overweight” rating in a research report on Wednesday, May 28th. Barclays lifted their target price on shares of Privia Health Group from $23.00 to $24.00 and gave the stock an “equal weight” rating in a research report on Tuesday, May 27th. Finally, Evercore ISI decreased their target price on shares of Privia Health Group from $30.00 to $28.00 and set an “outperform” rating for the company in a research note on Wednesday, July 9th.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the company. Durable Capital Partners LP lifted its stake in shares of Privia Health Group by 3.4% in the 4th quarter. Durable Capital Partners LP now owns 11,487,843 shares of the company’s stock worth $224,587,000 after purchasing an additional 378,255 shares during the period. State Street Corp increased its holdings in Privia Health Group by 1.5% during the second quarter. State Street Corp now owns 4,171,069 shares of the company’s stock valued at $95,935,000 after buying an additional 61,853 shares during the last quarter. Geode Capital Management LLC boosted its stake in shares of Privia Health Group by 6.3% during the 2nd quarter. Geode Capital Management LLC now owns 2,655,569 shares of the company’s stock worth $61,086,000 after acquiring an additional 158,521 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its stake in shares of Privia Health Group by 180.4% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 2,633,040 shares of the company’s stock worth $59,112,000 after purchasing an additional 1,693,870 shares in the last quarter. Finally, Van Berkom & Associates Inc. bought a new position in Privia Health Group in the 1st quarter worth $45,207,000. 94.48% of the stock is owned by hedge funds and other institutional investors.

Privia Health Group Stock Up 1.7%

NASDAQ:PRVA opened at $21.75 on Thursday. The stock has a market cap of $2.67 billion, a price-to-earnings ratio of 197.75, a PEG ratio of 3.10 and a beta of 0.80. The company’s 50 day moving average price is $20.89 and its 200-day moving average price is $22.68. Privia Health Group has a 52 week low of $16.47 and a 52 week high of $26.09.

Privia Health Group (NASDAQ:PRVA) last released its quarterly earnings data on Thursday, August 7th. The company reported $0.02 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.05 by ($0.03). Privia Health Group had a net margin of 0.78% and a return on equity of 2.13%. The business had revenue of $521.15 million during the quarter, compared to the consensus estimate of $466.97 million. During the same period last year, the company posted $0.19 earnings per share. The business’s revenue was up 23.4% compared to the same quarter last year. Privia Health Group has set its FY 2025 guidance at EPS. As a group, sell-side analysts anticipate that Privia Health Group will post 0.14 earnings per share for the current year.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.